No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Pharma Foods International Co., Ltd. is a Japanese enterprise dedicated to the research, development, and commercialization of ingredients for functional foods. Its diverse product portfolio features items such as Pharma-GABA, Bonepep, Ovopron (a specific egg yolk globulin), Delicious Catechin, RunPep, and enriched Folic Acid Egg. Additionally, the company offers iHA, a compound recognized for stimulating the body's hyaluronic acid production. Furthermore, Pharma Foods International Co., Ltd. has entered into a licensing arrangement with Mitsubishi Tanabe Pharma Corporation for a novel therapeutic antibody designed to combat autoimmune conditions. The firm was founded in 1997 and maintains its corporate headquarters in Kyoto, Japan.
www.pharmafoods.co.jpNo one on the platform currently holds 2929.T.
No tracked institution reports a position in 2929.T as of their last filing.
No one on the platform has traded 2929.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 10.0% | 11.8% | 20.4% | — | — | — |
| Rev. Growth % | -3.1% | 6.2% | ||||
| Profit Margin % | 3.1% | 2.5% | 3.6% | |||
| Free Cash Flow Margin % | -8.2% | -1.3% | 0.4% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $69.5B | +4.3% | $54.40 | $54.40–$54.40 | — | 1 |
| 2028 | $72.7B | +4.6% | $59.22 | $59.22–$59.22 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 2929.TPharma Foods International Co., Ltd. | $712.00 | +3.04% | $20.7B | — |
| 2374.TSaint-Care Holding Corporation | $1212.00 | +0.00% | $29.9B | — |
| 3417.TOhki Healthcare Holdings Co.,Ltd. | $1003.00 | +0.30% | $13.7B | — |
| 3649.TFINDEX Inc. | $915.00 | +4.57% | $22.3B | — |
| 3939.TKanamic Network Co.,LTD | $490.00 | -0.61% | $23.3B | — |
| 4538.TFuso Pharmaceutical Industries,Ltd. | $2231.00 | +1.64% |
Source: Financial Modeling Prep · peers by sector/industry
| $19.0B |
| — |
| 4574.TTaiko Pharmaceutical Co.,Ltd. | $258.00 | +1.18% | $13.0B | — |